VRCA
insider transactionsVerrica Pharmaceuticals Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Chief Operating Officer
$0
171.3K sh
Own New
-
Grant·A
$0
233.8K sh
Own New
-
Grant·A
Jayson Rieger KEY
CEO and President
$0
512.3K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Director
$0
16.0K sh
Own New
-
Grant·A
Diem Nguyen KEY
Chief Executive Officer
$0
272.2K sh
Own New
-
Exercise·M
Diem Nguyen KEY
Chief Executive Officer
$0
85.0K sh
Own +100%
-
Other·F
Diem Nguyen KEY
Chief Executive Officer
$247.4K
47.0K sh · $5.26
Own -25%
-
Exercise·M
Diem Nguyen KEY
Chief Executive Officer
$0
85.0K sh
Own +84%
-
Exercise·M
Diem Nguyen KEY
Chief Executive Officer
$0
55.9K sh
Own +5590200%
-
Other·F
Diem Nguyen KEY
Chief Executive Officer
$155.5K
22.8K sh · $6.82
Own -18%
-
Exercise·M
Diem Nguyen KEY
Chief Executive Officer
$0
55.9K sh
Own +83%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | David Zawitz | Grant A | 171.3K | $0 |
| Jun 5, 2026 | Noah L. Rosenberg | Grant A | 233.8K | $0 |
| Jun 5, 2026 | Jayson Rieger KEY | Grant A | 512.3K | $0 |
| Jun 5, 2026 | Mark A Prygocki SR | Grant A | 16.0K | $0 |
| Jun 5, 2026 | Diem Nguyen | Grant A | 16.0K | $0 |
| Jun 5, 2026 | Lawrence Eichenfield | Grant A | 16.0K | $0 |
| Jun 5, 2026 | Gavin Corcoran | Grant A | 16.0K | $0 |
| Mar 13, 2026 | Diem Nguyen KEY | Grant A | 272.2K | $0 |
| Mar 13, 2026 | Diem Nguyen KEY | Exercise M | 85.0K | $0 |
| Mar 13, 2026 | Diem Nguyen KEY | Other F | 47.0K | $247.4K |
| Mar 13, 2026 | Diem Nguyen KEY | Exercise M | 85.0K | $0 |
| Jan 27, 2026 | Diem Nguyen KEY | Exercise M | 55.9K | $0 |
| Jan 27, 2026 | Diem Nguyen KEY | Other F | 22.8K | $155.5K |
| Jan 27, 2026 | Diem Nguyen KEY | Exercise M | 55.9K | $0 |
About VRCA insider trading
This page tracks insider transactions for Verrica Pharmaceuticals Inc. (VRCA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.